Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.930
+0.110 (6.04%)
At close: Mar 9, 2026, 4:00 PM EDT
1.850
-0.080 (-4.15%)
After-hours: Mar 9, 2026, 7:31 PM EDT

Coherus Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
2881721593717781,225
Upgrade
Market Cap Growth
127.69%7.95%-57.13%-52.31%-36.55%-2.13%
Upgrade
Enterprise Value
155343617189711,176
Upgrade
Last Close Price
1.931.421.383.337.9215.96
Upgrade
PE Ratio
1.351.025.58---
Upgrade
PS Ratio
6.844.070.601.443.683.75
Upgrade
PB Ratio
3.832.81-1.20-1.92-5.6612.54
Upgrade
P/TBV Ratio
19.5211.62---13.02
Upgrade
EV/Sales Ratio
3.670.811.352.794.603.60
Upgrade
Debt / Equity Ratio
0.630.63-2.26-2.49-3.504.29
Upgrade
Net Debt / Equity Ratio
-2.19-2.19-1.31-1.88-2.100.02
Upgrade
Net Debt / EBITDA Ratio
0.750.75-1.94-1.92-1.14-0.01
Upgrade
Net Debt / FCF Ratio
0.970.97-8.45-2.08-1.20-0.05
Upgrade
Asset Turnover
0.120.120.500.460.360.43
Upgrade
Inventory Turnover
0.380.381.773.141.831.41
Upgrade
Quick Ratio
1.361.360.881.142.173.27
Upgrade
Current Ratio
1.471.471.211.432.753.64
Upgrade
Return on Equity (ROE)
------151.62%
Upgrade
Return on Assets (ROA)
-32.03%-32.03%-10.94%-21.75%-27.68%-21.68%
Upgrade
Return on Invested Capital (ROIC)
---89.73%-120.38%-204.79%-205.76%
Upgrade
Return on Capital Employed (ROCE)
-153.60%-153.60%-57.00%-64.90%-75.10%-51.30%
Upgrade
Earnings Yield
58.24%97.89%17.93%-64.15%-37.52%-23.43%
Upgrade
FCF Yield
-48.01%-80.70%-12.86%-47.16%-31.01%-3.16%
Upgrade
Buyback Yield / Dilution
-2.26%-2.01%-21.95%-21.30%-2.89%9.63%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.